| URL | https://infabode.com/post/1568669?token=7301f0f183 |
| Source | Infabode |
| Date Published | 04/24/2026 |
| Company/Division name | AbbVie |
| Parent company | AbbVie |
| Reshoring category: | Reshoring |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 70 |
| City reshored to: | Worcester |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceutical drugs |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Manufacturing/engineering joint innovation (R&D) |